Global Muscle Wasting Disorders Market Research Report By Types, Applications, Regions, Countries and Forecast to 2030
Report Code: KNJ1756929 No. of Pages: 220 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Muscle Wasting Disorders Market Research Report is a valuable source of perceptive data for business strategists. It provides industry overview with various point views; that include the availability of data, facts, and figures, past performance, trends, and way of approaching in the market. This research study of Muscle Wasting Disorders involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, and present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry. An in-depth analysis of global Muscle Wasting Disorders market presents in the report. An informative overview of market has been highlighted that sheds light on the market definition, application of the market offerings and the production methodology that is organized in the industry setting. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR for the period of 2024-2030. Muscle Wasting Disorders Market Segmentation Analysis: Market Segment By Type:- Muscular Dystrophy (Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy (BMD), Myotonic Muscular Dystrophy, Congenital Muscular Dystrophy, Limb-Girdle Muscular Dystrophy, Others (Oculopharyngeal Muscular Dystrophy, Emery-Dreifuss Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy, etc.) Muscular Atrophy- Physiologic Atrophy, Pathologic Atrophy, Neurogenic Atrophy Market Segment By Application:- Medications Physical Therapy (Ultrasound Therapy, Electric Simulation) Nutritional Therapy Surgery Gene Therapy Others (Occupational Therapy, Respiratory Therapy, Assistive Devices, etc.) Market Segment By End-User:- Hospitals Rehab Centers Specialty Clinics Others (Homecare, etc.) Regional and Country-level Analysis North America (U.S., Canada, Mexico) Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe) Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC) South America (Brazil, Argentina, Rest of SA) Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA). The report includes country-wise and region-wise market size for the period 2018-2030. It also includes market size and forecast in terms of sales and revenue for the period 2018-2030. Competitive Landscape and Muscle Wasting Disorders Market Share Analysis Muscle Wasting Disorders market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2018-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2018-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Muscle Wasting Disorders business, the date to enter into the Muscle Wasting Disorders market, Muscle Wasting Disorders product introduction, recent developments, etc. The Major Key Players Covered: Biogen, Inc. F. Hoffmann-La Roche Ltd Novartis AG Ionis Pharmaceuticals, Inc. Sarepta Therapeutics, Inc. Nippon Shinyaku Co., Ltd. (NS Pharma, Inc.) PTC Therapeutics, Inc. Teva Pharmaceutical Industries Ltd. Pfizer Inc. Santhera Pharmaceuticals Holding AG Cytokinetics, Incorporated Italfarmaco S.p.A. Acceleron Pharma Inc. FibroGen, Inc. FAQ'S Q. 1. What is the vision of Muscle Wasting Disorders Market? Q. 2. Does this report estimate the current market size? Q. 3. Does the report delivers market size in terms of - Value (US$ Mn/Bn) and Volume of the market? Q. 4. Who are the prominent players in the Muscle Wasting Disorders Market? Q. 5. Which various segments are covered in Muscle Wasting Disorders Market? Q. 6. What are the key factors covered in Muscle Wasting Disorders Market? Q. 7. Does this report offer customization? We can offer customization in the report without any extra charges and get research data or trends added in the report as per the buyer’s specific requirements.
1 Report Overview
1.1 Muscle Wasting Disorders Definition
1.2 Market by Type
1.2.1 Global Muscle Wasting Disorders Market Size Growth Rate by Type, 2018 VS 2022 VS 2030
1.2.2 Muscular Dystrophy
1.2.3 Muscular Atrophy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Muscle Wasting Disorders Market Size Growth Rate by Application, 2018 VS 2022 VS 2030
1.3.2 Medications
1.3.3 Physical Therapy (Ultrasound Therapy, Electric Simulation)
1.3.4 Nutritional Therapy
1.3.5 Surgery
1.3.6 Gene Therapy
1.3.7 Others (Occupational Therapy, Respiratory Therapy, Assistive Devices, etc.)
1.4 Market by Platform (Digital)
1.4.1 Global Muscle Wasting Disorders Market Size Growth Rate by End-User, 2018 VS 2022 VS 2030
1.4.2 Hospitals
1.4.3 Rehab Centers
1.4.4 Specialty Clinics
1.4.5 Others (Homecare, etc.)
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Global Muscle Wasting Disorders Sales
2.1 Global Muscle Wasting Disorders Revenue Estimates and Forecasts 2018-2030
2.2 Global Muscle Wasting Disorders Revenue by Region: 2018 VS 2022 VS 2030
2.3 Global Muscle Wasting Disorders Revenue by Region
2.3.1 Global Muscle Wasting Disorders Revenue by Region (2018-2023)
2.3.2 Global Muscle Wasting Disorders Revenue by Region (2024-2030)
2.4 Global Muscle Wasting Disorders Sales Quantity Estimates and Forecasts 2018-2030
2.5 Global Muscle Wasting Disorders Sales Quantity by Region: 2018 VS 2022 VS 2030
2.6 Global Muscle Wasting Disorders Sales Quantity by Region
2.6.1 Global Muscle Wasting Disorders Sales Quantity by Region (2018-2023)
2.6.2 Global Muscle Wasting Disorders Sales Quantity by Region (2024-2030)
2.7 North America
2.8 Europe
2.9 APAC
2.11 Middle East, Africa and Latin America
3 Global Production (Based on Production Site)
3.1 Global Muscle Wasting Disorders Production Value by Region: 2018 VS 2022 VS 2030
3.2 Global Muscle Wasting Disorders Production Value by Region
3.2.1 Global Muscle Wasting Disorders Historic Production Value by Region (2018-2023)
3.2.2 Global Muscle Wasting Disorders Forecasted Production Value by Region (2024-2030)
3.3 Global Muscle Wasting Disorders Production Capacity (2018-2030)
3.4 Global Muscle Wasting Disorders Production by Region: 2018 VS 2022 VS 2030
3.5 Global Muscle Wasting Disorders Production by Region
3.5.1 Global Muscle Wasting Disorders Historic Production by Region (2018-2023)
3.5.2 Global Muscle Wasting Disorders Forecasted Production by Region (2024-2030)
3.5.3 North America
3.5.4 Europe
3.5.5 Japan
3.5.6 China
3.5.7 South Korea
3.5.8 India
4 Competition by Manufacturers
4.1 Global Muscle Wasting Disorders Sales Quantity by Manufacturers
4.1.1 Global Muscle Wasting Disorders Sales Quantity by Manufacturers (2018-2023)
4.1.2 Global Muscle Wasting Disorders Sales Quantity Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Companies by Muscle Wasting Disorders Sales in 2022
4.2 Global Muscle Wasting Disorders Revenue by Manufacturers
4.2.1 Global Muscle Wasting Disorders Revenue by Manufacturers (2018-2023)
4.2.2 Global Muscle Wasting Disorders Revenue Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Muscle Wasting Disorders Revenue in 2022
4.3 Global Muscle Wasting Disorders Sales Price by Manufacturers
4.4 Global Key Players of Muscle Wasting Disorders, Industry Ranking, 2021 VS 2022
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market PTC Therapeutics, Inc.tion Ratio (CR5 and HHI)
4.5.2 Global Muscle Wasting Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Muscle Wasting Disorders, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Muscle Wasting Disorders, Product Offered and Application
4.8 Global Key Manufacturers of Muscle Wasting Disorders, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Estimates and Forecasts by Type
5.1 Global Muscle Wasting Disorders Sales Quantity by Type
5.1.1 Global Muscle Wasting Disorders Historical Sales Quantity by Type (2018-2023)
5.1.2 Global Muscle Wasting Disorders Forecasted Sales Quantity by Type (2024-2030)
5.1.3 Global Muscle Wasting Disorders Sales Quantity Market Share by Type (2018-2030)
5.2 Global Muscle Wasting Disorders Revenue by Type
5.2.1 Global Muscle Wasting Disorders Historical Revenue by Type (2018-2023)
5.2.2 Global Muscle Wasting Disorders Forecasted Revenue by Type (2024-2030)
5.2.3 Global Muscle Wasting Disorders Revenue Market Share by Type (2018-2030)
5.3 Global Muscle Wasting Disorders Price by Type
5.3.1 Global Muscle Wasting Disorders Price by Type (2018-2023)
5.3.2 Global Muscle Wasting Disorders Price Forecast by Type (2024-2030)
6 Market Size by Application
6.1 Global Muscle Wasting Disorders Sales Quantity by Application
6.1.1 Global Muscle Wasting Disorders Historical Sales Quantity by Application (2018-2023)
6.1.2 Global Muscle Wasting Disorders Forecasted Sales Quantity by Application (2024-2030)
6.1.3 Global Muscle Wasting Disorders Sales Quantity Market Share by Application (2018-2030)
6.2 Global Muscle Wasting Disorders Revenue by Application
6.2.1 Global Muscle Wasting Disorders Historical Revenue by Application (2018-2023)
6.2.2 Global Muscle Wasting Disorders Forecasted Revenue by Application (2024-2030)
6.2.3 Global Muscle Wasting Disorders Revenue Market Share by Application (2018-2030)
6.3 Global Muscle Wasting Disorders Price by Application
6.3.1 Global Muscle Wasting Disorders Price by Application (2018-2023)
6.3.2 Global Muscle Wasting Disorders Price Forecast by Application (2024-2030)
7 North America
7.1 North America Muscle Wasting Disorders Sales by Company
7.1.1 North America Muscle Wasting Disorders Revenue by Company (2018-2023)
7.1.2 North America Muscle Wasting Disorders Sales Quantity by Company (2018-2023)
7.2 North America Muscle Wasting Disorders Market Size by Type
7.2.1 North America Muscle Wasting Disorders Sales Quantity by Type (2018-2030)
7.2.2 North America Muscle Wasting Disorders Revenue by Type (2018-2030)
7.3 North America Muscle Wasting Disorders Market Size by Application
7.3.1 North America Muscle Wasting Disorders Sales Quantity by Application (2018-2030)
7.3.2 North America Muscle Wasting Disorders Revenue by Application (2018-2030)
7.4 North America Muscle Wasting Disorders Market Size by Country
7.4.1 North America Muscle Wasting Disorders Revenue by Country: 2018 VS 2022 VS 2030
7.4.2 North America Muscle Wasting Disorders Revenue by Country (2018-2030)
7.4.3 North America Muscle Wasting Disorders Sales Quantity by Country (2018-2030)
7.4.4 U.S.
7.4.5 Canada
8 Europe
8.1 Europe Muscle Wasting Disorders Sales by Company
8.1.1 Europe Muscle Wasting Disorders Sales Quantity by Company (2018-2023)
8.1.2 Europe Muscle Wasting Disorders Revenue by Company (2018-2023)
8.2 Europe Muscle Wasting Disorders Market Size by Type
8.2.1 Europe Muscle Wasting Disorders Sales Quantity by Type (2018-2030)
8.2.2 Europe Muscle Wasting Disorders Revenue by Type (2018-2030)
8.3 Europe Muscle Wasting Disorders Market Size by Application
8.3.1 Europe Muscle Wasting Disorders Sales Quantity by Application (2018-2030)
8.3.2 Europe Muscle Wasting Disorders Revenue by Application (2018-2030)
8.4 Europe Muscle Wasting Disorders Market Size by Country
8.4.1 Europe Muscle Wasting Disorders Revenue by Country: 2018 VS 2022 VS 2030
8.4.2 Europe Muscle Wasting Disorders Revenue by Country (2018-2030)
8.4.3 Europe Muscle Wasting Disorders Sales Quantity by Country (2018-2030)
8.4.4 Germany
8.4.5 France
8.4.6 U.K.
8.4.7 Italy
8.4.8 Russia
9 APAC
9.1 APAC Muscle Wasting Disorders Sales by Company
9.1.1 APAC Muscle Wasting Disorders Sales Quantity by Company (2018-2023)
9.1.2 APAC Muscle Wasting Disorders Revenue by Company (2018-2023)
10.2 APAC Muscle Wasting Disorders Market Size by Type
9.2.1 APAC Muscle Wasting Disorders Sales Quantity by Type (2018-2030)
9.2.2 APAC Muscle Wasting Disorders Revenue by Type (2018-2030)
9.3 APAC Muscle Wasting Disorders Market Size by Application
9.3.1 APAC Muscle Wasting Disorders Sales Quantity by Application (2018-2030)
9.3.2 APAC Muscle Wasting Disorders Revenue by Application (2018-2030)
9.4 APAC Muscle Wasting Disorders Market Size by Region
9.4.1 APAC Muscle Wasting Disorders Revenue by Region: 2018 VS 2022 VS 2030
9.4.2 APAC Muscle Wasting Disorders Revenue by Region (2018-2030)
9.4.3 APAC Muscle Wasting Disorders Sales Quantity by Region (2018-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China
9.4.7 Taiwan
9.4.8 Southeast Asia
9.4.9 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Muscle Wasting Disorders Sales by Company
10.1.1 Middle East, Africa and Latin America Muscle Wasting Disorders Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Muscle Wasting Disorders Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Muscle Wasting Disorders Market Size by Type
10.2.1 Middle East, Africa and Latin America Muscle Wasting Disorders Sales Quantity by Type (2018-2030)
10.2.2 Middle East, Africa and Latin America Muscle Wasting Disorders Revenue by Type (2018-2030)
10.3 Middle East, Africa and Latin America Muscle Wasting Disorders Market Size by Application
10.3.1 Middle East, Africa and Latin America Muscle Wasting Disorders Sales Quantity by Application (2018-2030)
10.3.2 Middle East, Africa and Latin America Muscle Wasting Disorders Revenue by Application (2018-2030)
10.4 Middle East, Africa and Latin America Muscle Wasting Disorders Market Size by Country
10.4.1 Middle East, Africa and Latin America Muscle Wasting Disorders Revenue by Country: 2018 VS 2022 VS 2030
10.4.2 Middle East, Africa and Latin America Muscle Wasting Disorders Revenue by Country (2018-2030)
10.4.3 Middle East, Africa and Latin America Muscle Wasting Disorders Sales Quantity by Country (2018-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Biogen, Inc.
11.1.1 Biogen, Inc. Company Information
11.1.2 Biogen, Inc. Overview
11.1.3 Biogen, Inc. Muscle Wasting Disorders Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
11.1.4 Biogen, Inc. Muscle Wasting Disorders Products and Services
11.1.5 Biogen, Inc. Muscle Wasting Disorders SWOT Analysis
11.1.6 Biogen, Inc. Recent Developments
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Information
11.2.2 F. Hoffmann-La Roche Ltd Overview
11.2.3 F. Hoffmann-La Roche Ltd Muscle Wasting Disorders Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
11.2.4 F. Hoffmann-La Roche Ltd Muscle Wasting Disorders Products and Services
11.2.5 F. Hoffmann-La Roche Ltd Muscle Wasting Disorders SWOT Analysis
11.2.6 F. Hoffmann-La Roche Ltd Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG Muscle Wasting Disorders Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
11.3.4 Novartis AG Muscle Wasting Disorders Products and Services
11.3.5 Novartis AG Muscle Wasting Disorders SWOT Analysis
11.3.6 Novartis AG Recent Developments
11.4 Ionis Pharmaceuticals, Inc.
11.4.1 Ionis Pharmaceuticals, Inc. Company Information
11.4.2 Ionis Pharmaceuticals, Inc. Overview
11.4.3 Ionis Pharmaceuticals, Inc. Muscle Wasting Disorders Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
11.4.4 Ionis Pharmaceuticals, Inc. Muscle Wasting Disorders Products and Services
11.4.5 Ionis Pharmaceuticals, Inc. Muscle Wasting Disorders SWOT Analysis
11.4.6 Ionis Pharmaceuticals, Inc. Recent Developments
11.5 Sarepta Therapeutics, Inc.
11.5.1 Sarepta Therapeutics, Inc. Company Information
11.5.2 Sarepta Therapeutics, Inc. Overview
11.5.3 Sarepta Therapeutics, Inc. Muscle Wasting Disorders Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
11.5.4 Sarepta Therapeutics, Inc. Muscle Wasting Disorders Products and Services
11.5.5 Sarepta Therapeutics, Inc. Muscle Wasting Disorders SWOT Analysis
11.5.6 Sarepta Therapeutics, Inc. Recent Developments
11.6 Nippon Shinyaku Co., Ltd. (NS Pharma, Inc.)
11.6.1 Nippon Shinyaku Co., Ltd. (NS Pharma, Inc.) Company Information
11.6.2 Nippon Shinyaku Co., Ltd. (NS Pharma, Inc.) Overview
11.6.3 Nippon Shinyaku Co., Ltd. (NS Pharma, Inc.) Muscle Wasting Disorders Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
11.6.4 Nippon Shinyaku Co., Ltd. (NS Pharma, Inc.) Muscle Wasting Disorders Products and Services
11.6.5 Nippon Shinyaku Co., Ltd. (NS Pharma, Inc.) Muscle Wasting Disorders SWOT Analysis
11.6.6 Nippon Shinyaku Co., Ltd. (NS Pharma, Inc.) Recent Developments
11.7 PTC Therapeutics, Inc.
11.7.1 PTC Therapeutics, Inc. Company Information
11.7.2 PTC Therapeutics, Inc. Overview
11.7.3 PTC Therapeutics, Inc. Muscle Wasting Disorders Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
11.7.4 PTC Therapeutics, Inc. Muscle Wasting Disorders Products and Services
11.7.5 PTC Therapeutics, Inc. Muscle Wasting Disorders SWOT Analysis
11.7.6 PTC Therapeutics, Inc. Recent Developments
11.8 Teva Pharmaceutical Industries Ltd.
11.8.1 Teva Pharmaceutical Industries Ltd. Company Information
11.8.2 Teva Pharmaceutical Industries Ltd. Overview
11.8.3 Teva Pharmaceutical Industries Ltd. Muscle Wasting Disorders Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
11.8.4 Teva Pharmaceutical Industries Ltd. Muscle Wasting Disorders Products and Services
11.8.5 Teva Pharmaceutical Industries Ltd. Muscle Wasting Disorders SWOT Analysis
11.8.6 Teva Pharmaceutical Industries Ltd. Recent Developments
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Information
11.9.2 Pfizer Inc. Overview
11.9.3 Pfizer Inc. Muscle Wasting Disorders Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
11.9.4 Pfizer Inc. Muscle Wasting Disorders Products and Services
11.9.5 Pfizer Inc. Muscle Wasting Disorders SWOT Analysis
11.9.6 Pfizer Inc. Recent Developments
11.10 Santhera Pharmaceuticals Holding AG
11.10.1 Santhera Pharmaceuticals Holding AG Company Information
11.10.2 Santhera Pharmaceuticals Holding AG Overview
11.10.3 Santhera Pharmaceuticals Holding AG Muscle Wasting Disorders Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
11.10.4 Santhera Pharmaceuticals Holding AG Muscle Wasting Disorders Products and Services
11.10.5 Santhera Pharmaceuticals Holding AG Muscle Wasting Disorders SWOT Analysis
11.10.6 Santhera Pharmaceuticals Holding AG Recent Developments
11.11 Cytokinetics, Incorporated
11.11.1 Cytokinetics, Incorporated Company Information
11.11.2 Cytokinetics, Incorporated Overview
11.11.3 Cytokinetics, Incorporated Muscle Wasting Disorders Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
11.11.4 Cytokinetics, Incorporated Muscle Wasting Disorders Products and Services
11.11.5 Cytokinetics, Incorporated Muscle Wasting Disorders SWOT Analysis
11.11.6 Cytokinetics, Incorporated Recent Developments
11.12 Italfarmaco S.p.A.
11.13 Acceleron Pharma Inc.
11.14 FibroGen, Inc.
12 Industry Chain and Sales Channels Analysis
12.1 Muscle Wasting Disorders Industry Chain Analysis
12.2 Muscle Wasting Disorders Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Muscle Wasting Disorders Production Mode & Process
12.4 Muscle Wasting Disorders Sales and Marketing
12.4.1 Muscle Wasting Disorders Sales Channels
12.4.2 Muscle Wasting Disorders Distributors
12.5 Muscle Wasting Disorders Customers
13 Market Dynamics
13.1 Muscle Wasting Disorders Industry Trends
13.2 Muscle Wasting Disorders Market Drivers
13.3 Muscle Wasting Disorders Market Challenges
13.4 Muscle Wasting Disorders Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com